CVE-2024-27088

Public Exploit
es5-ext Regular Expression Denial of Service in `function#copy` and `function#toStringTokens`

Description

es5-ext contains ECMAScript 5 extensions. Passing functions with very long names or complex default argument names into `function#copy` or `function#toStringTokens` may cause the script to stall. The vulnerability is patched in v0.10.63.

Categories

N/A
CVSS
Severity: Low
EPSS 1.85% Top 20%
Vendor Advisory github.com
Affected: medikoo es5-ext
Published at:
Updated at:

References

Link Tags
https://github.com/medikoo/es5-ext/security/advisories/GHSA-4gmj-3p3h-gm8h patch vendor advisory
https://github.com/medikoo/es5-ext/issues/201 issue tracking exploit
https://github.com/medikoo/es5-ext/commit/3551cdd7b2db08b1632841f819d008757d28e8e2 patch
https://github.com/medikoo/es5-ext/commit/a52e95736690ad1d465ebcd9791d54570e294602 patch

Frequently Asked Questions

What is the severity of CVE-2024-27088?
CVE-2024-27088 has not yet been assigned a CVSS score.
How to fix CVE-2024-27088?
To fix CVE-2024-27088, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-27088 being actively exploited in the wild?
It is possible that CVE-2024-27088 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27088?
CVE-2024-27088 affects medikoo es5-ext.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.